booksshare.net -> -> -> .. -> " " -> 232

- ..

.., .. .: , 2008. 224 c.
ISBN 978-5-9704-0578-9
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 226 227 228 229 230 231 < 232 > 233 234 235 236 237 238 .. 345 >>

DBP 1 227 908 (E. Merck AG; Anm. 8.2.1964).
DOS 1 695 402 (E. Merck AG; Anm. 25.3.1967).
794 P Pyritinol - Pyrovaleron - Pyrrobutamin
D: Encephabol® (Merck)
F: Biontabol® (Merck-Clevenot)-Komb.
Encephabol® (Merck-Clevenot)
I: Biocefalin® (Benvegna)
Cefalogen® (Montefarmaco) Cerebropirina® (Chemil)
Cerebrotrofina® (Nuovo Cons. Sanit. Naz.) Cervitalin® (Savoma)
Encebrovit® (Sierochimica)
Encefabol® (Bracco)
Encefort® (Intersint)
Encerebron® (Pulitzer)
Evolubran® (Abe)
Fulneurina® (Fulton)
Gladius® (Smith Kline & French)
Leonar® (Kalopharma)
Life® (Sit)
Maind® (Also)
Miriplex® (Poli)
Musa® (Poli)
Piritinol® (Magis)
Scintidin® (Ici)
Tonobrein® (Ct) Tonomentis® (Ion) Chioebon® (Kyowa Yakuhin) Divalvon® (Nippon Kayaku) Enboi® (Merck-Chugai) Neurotin® (Nakataki) Neuroxin® (Yamanouchi) Piritiomin® (Hishiyama)
Pyrovaleron
3563-49-3
1147-62-2 Hydrochlorid
zentrales Stimulans
4'-methyl-2-(l-pyrrolidinyl)valerophenone
НзС
C-CHj
0 CH2-CHj-CH3 p- Methylvalerophenon
H3c _
б CH2 — CH2~ CH3 a -Brom - 4 - met hylvalerophenon

0 CH2-CH2-CH3|
Pyrovaleron
GB-P 933 507 (Thomae; Anm. 4.4.1961; D-Prior. 7.4.1960).
GB-P 927 475 (Dr. A. Wander; Anm. 18.5.1961; CH-Prior. 24.5.1960).
F: Thymergix® (Joullie)
Pyrrobutamin
91-82-7
135-31-9
Phosphat
Antihistaminicum
‘ pyrrolidine, l-[4-(4-chlorophenyl)-3-phenyl-2-butenyl]-
^ А"-, Cl—(T^-CHj-MgCl
C-CH3 + (CH20)n + HN j -»■ C-CH2-CH2-N — w
> \*— f t*-1
Acetophenon
Paraform-
aldehyd
Chlorbenzylmagne-siumchlorid bzw. к - Chtor bemylchlorid
Pyrroli -din
ш-Pyrrolidinopropiophenon
Pyrrobutamin - Pyrrocain - Pyrrolnitrin P 795
c.-Q-ch2
c=ch-ch2-n 1
Pyrrobutamin
USP 2 655 509 (Eli Lilly; ert. 1953; Prior. 1951).
D: Copyronilum® (LiUy)-Komb. USA: Co-Pyronil® (Lilly)-Komb.
GB: Co-Pyronil® (Lilly)-Komb.
Pyrrocain 2210-77-7 Lokalanastheticum
2210-64-2 Hydrochlorid
l-pyrrolidineaceto-2',6'-xylidide
CH3
. CH3
NH2 + Cl-CO-CH2“Ct Na0 C°—rfo/-HaQ » NH-C0-CH2-Cl
CH3
CH3
2,6-Oimethyl- Chloracetylchtorid aniiin
a-Chlor-2,6-dimethylacetamlid
l СНЗ
I /—(
Pytrolidin \
CH3
Pyrrocain
N. Lofgren et al., Acta Chem. Scand. 11,1724 (1957).
USA: Dynacaine® (Graham) Endocaine® (Endo)
Pyrrolnitrin
1018-71-9
Antibioticum
3-chloro-4-(3-chloro-2-nitrophenyl)pyrrole
H5C2OOC
I .N CH3 COOC2H5 H5C2OOC-CH
—CO~CH2“CO —CH3 <■ ch-nh2 --► <^_V-C0-CH2
Cl N02 COOC2H5 a nq2
l-(2-Nitro-3-chlorphenyt)-l,3- Aminomalon-butandion saurediethylester
796 P Pyrrolnitrin - Pyrvinium-embonat
Pyrrolnitrin
USP 3428 648 (Fujisawa; ert. 18.2.1969; J-Prior. 8.4.1965,2.2.1965, 4.12.1964, 7.12.1964, 22.10.1964, 12.10.1964).
H. Nakano et al., Tetrahedron Lett. 1966,737 (auch weitere Verfahren).
Isolierung aus Pseudomonas:
K. Arina et al., Agric. Biol. Chem. 28, 575 (1964).
D'. Antimycoticum Klinger (Dr. Klinger)-Komb. J: Pyroace® (Fujisawa)
I: Micutrin® (ISF) USA: Pyrrolnitrin (Lilly)
Pyrvinium-embonat 3546-41 -6 Anthelminticum
(= -pamoat)
6-dimethylamino-2-[2-(2,5-dimethyl-l-phenyl-3-pyrrolyl)vmyl]-methylquinolinium embonate
toi
H3C
I
✓N
H,C
^ СНз CH3
1,2-Dimethyl-
6-dimethylamino-
chinoliniumjodid
2,5-Dimethyl-
l-phenylpyrrol-
3-carboxaldehyd
Pipendin
H3C
N ^CH=CH-^ 0H3
CH3
H3C X)
Pyrvimumjodid
Pamoasaure
'**1
Pyrvinium-jodid und chlorid:
USP2 515 912 (Eastman Kodak; ert. 1950; Prior. 1946). Pyrvinium-embonat:
USP2925417 (Parke-Davis; ert. 16.2.1960; Prior. 6.11.1957).
Pyrvinium-embonat--Quinestrol - Quinethazon P/Q 797
D: Molevac® (Parke-Davis) F: Povanyl® (Parke-Davis) I: Vanquin® (Parke-Davis)
Vermitiber® (Tiber)
J: Poquil® (Parke -Davis-Sankyo) USA: Povan® (Parke-Davis)
Quinestrol
152-43-2
Oestrogen
3-cyclopentyloxy-17a-ethynylestra-l,3,5(10)-triene-17/J-ol
О
•Br
Cyclopentyl-
bromid
СУ0'
Estron-3-cyctopentylether
HC5CH / KQC(CH a)3 Acetyten/Kalium-
ferf-butylat
17a-Ethinyloestradiol
(17cr-Ettiinyl-3J7/3-dihydroxy-
I^.S^-oestratrtenj
О
K2C03
Br -► Quinestrol
Cyclopentyl-
bromid
USP 3 159 543 (F. Vismara S.p.A.; ert. 1.12.1964; I-Prior. 7.4.1961).
DAS 1 157 610 (F. Vismara S.p.A.; Anm. 7.2.1961; I-Prior. 8.2.1960,13.12.1960). A. Ercoli, R. Gardi, Chem. Ind. (London) 1961,1037.
Weitere Verfahren:
USP 3 231 567 (F. Vismara; ert. 25.1.1966; I-Prior. 16.12.1963).
Belg-P 641 351 (F. Vismara; Anm. 16.12.1963; I-Prior. 19.12.1962, 30.9.1963).
D: Estrovis® (Godecke) GB: Estrovis® (Warner)
I: Estrovis® (Vister)
USA: Estrovis® (Warner-Chilcott)
Quinethazon
(Chinethazonum)
73-49-4
Diureticum;
Antihypertonicum
7-chloro-2-ethyl-l,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide
798 Q Quinethazon - Quingestanolacetat
h,n-so,^^'c-'NH2
\
,C-C2H5
H C,H5 nh2
5-Aminosulfonyl-4-chlor-
anthranilsaureamid
Phosphor-
oxychtorid
Propionyl-
chlorid
h2n-so2'^/Y
n^c2h5
AIC^/NaBHt
Aluminium- ! _ _ ,
chlorid / Natrium- i h^N-SOj
boranat j
Cl^ ^ .N^CjHs | NH |
S-Aminosulfonyi-7-chlor-4-
ЗАУ-chinazolon
<< 1 .. 226 227 228 229 230 231 < 232 > 233 234 235 236 237 238 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed